Huayan Xu

Dr. Huayan Xu

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Clinica Chimica Acta
Verified
Journal Article
Closed access
XLXiaoyan Li
Xiaoyan Li
YLYi Liu
Yi Liu
WSWeiwei Shi
Weiwei Shi
HXHuayan Xu
Huayan Xu
HHHaixu Hu
Haixu Hu
XLXiaoqing Liu
Xiaoqing Liu

5 September 2023 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
HXHuayan Xu
Huayan Xu
XCXiaotang Cai
Xiaotang Cai
KXKe Xu
Ke Xu
QWQihong Wu
Qihong Wu
BXBei Xu
Bei Xu
Background: Duchenne muscular dystrophy (DMD) is a fatal genetic muscle-wasting disease that affects 1 in 5000 male births with no current cure. Despite great progress has been made in the research of DMD, its underlying pathological mechanism based on the metabolomics is still worthy of further study. Therefore, it is necessary to gain a deeper understanding of the mechanisms or pathogenesis underlying DMD, which may reveal potential therapeutic targets and/or biomarkers. Results: Plasma samples from 42 patients with DMD from a natural history study and 40 age-matched healthy volunteers were subjected to a liquid chromatography-mass spectrometry-based non-targeted metabolomics approach. Acquired metabolic data were evaluated by principal component analysis, partial least squares-discriminant analysis, and metabolic pathway analysis to explore distinctive metabolic patterns in patients with DMD. Differentially expressed metabolites were identified using publicly available and integrated databases. By comparing the DMD and healthy control groups, 25 differential metabolites were detected, including amino acids, unsaturated fatty acids, carnitine, lipids, and metabolites related to the gut microbiota. Correspondingly, linoleic acid metabolism, D-glutamine and D-glutamate metabolism, glycerophospholipid metabolism, and alanine, aspartate, and glutamate metabolism were significantly altered in patients with DMD, compared with those of healthy volunteers. Conclusions: Our study demonstrated the abnormal metabolism of amino acids, energy, and lipids in patients with DMD, consistent with pathological features, such as recurrent muscle necrosis and regeneration, interstitial fibrosis, and fat replacement. Additionally, we found that metabolites of intestinal flora were disordered in DMD patients, providing support for treatment of intestinal microbia disturbance in DMD diseases. Our study provides a new research strategy for understanding the pathogenesis of DMD.

20 November 2023 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
YGYue Gao
Yue Gao
YJYi-Ning Jiang
Yi-Ning Jiang
RSRui Shi
Rui Shi
YGYing-Kun Guo
Ying-Kun Guo
HXHuayan Xu
Huayan Xu
YLYuan Li
Yuan Li
Background: Diabetes mellitus (DM) is the most common metabolic disease worldwide and a major risk factor for adverse cardiovascular events, while the additive effects of DM on left ventricular (LV) deformation in the restrictive cardiomyopathy (RCM) cohort remain unclear. Accordingly, we aimed to investigate the additive effects of DM on LV deformation in patients with RCM. Materials and methods: One hundred thirty-six RCM patients without DM [RCM(DM−)], 46 with DM [RCM (DM+)], and 66 age- and sex-matched control subjects who underwent cardiac magnetic resonance (CMR) scanning were included. LV function, late gadolinium enhancement (LGE) type, and LV global peak strains (including radial, circumferential, and longitudinal directions) were measured. The determinant of reduced LV global myocardial strain for all RCM patients was assessed using multivariable linear regression analyses. The receiver operating characteristic curve (ROC) was performed to illustrate the relationship between DM and decreased LV deformation. Results: Compared with the control group, RCM (DM−) and RCM(DM+) patients presented increased LV end-diastolic index and end-systolic volume index and decreased LV ejection fraction. LV GPS in all three directions and longitudinal PDSR progressively declined from the control group to the RCM(DM−) group to the RCM(DM+) group (all p < 0.05). DM was an independent determinant of impaired LV GPS in the radial, circumferential, and longitudinal directions and longitudinal PDSR (β = − 0.217, 0.176, 0.253, and − 0.263, all p < 0.05) in RCM patients. The multiparameter combination, including DM, showed an AUC of 0.81(95% CI 0.75–0.87) to predict decreased LV GLPS and an AUC of 0.69 (95% CI 0.62–0.76) to predict decreased LV longitudinal PDSR. Conclusions: DM may have an additive deleterious effect on LV dysfunction in patients with RCM, especially diastolic dysfunction in RCM patients, indicating the importance of early identification and initiation of treatment of DM in patients with RCM.

8 February 2024 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
ZZZiqi Zhou
Ziqi Zhou
RXRong Xu
Rong Xu
XCXiaotang Cai
Xiaotang Cai
HFHang Fu
Hang Fu
KXKe Xu
Ke Xu
HXHuayan Xu
Huayan Xu

11 February 2023 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
TXTing Xu
Ting Xu
KXKe Xu
Ke Xu
YSYu Song
Yu Song
ZZZiqi Zhou
Ziqi Zhou
HFHang Fu
Hang Fu
HXHuayan Xu
Huayan Xu

2 April 2025 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
XZXinyuan Zhang
Xinyuan Zhang
HLHengxin Li
Hengxin Li
XNXiaoyu Niu
Xiaoyu Niu
HFHang Fu
Hang Fu
RXRong Xu
Rong Xu
HXHuayan Xu
Huayan Xu